☑ Platform for continuous monitoring of variety of biomarker levels
☑ Lends itself to critical conditions and/or where drug dosing is critical
☑ Currently only available continuous monitoring products are for glucose only (Medtronic, Abbott) – Southwest Sensor platform could do almost any marker
☑ Currently developing first test with targeted CE marking 2019.
☑ Versatility already demonstrated through proof-of-concept data for glucose, lactate (both electrochemical) and cortisol (ELISA based)